Skip to main content
Journal cover image

Child/Adolescent anxiety multimodal study: evaluating safety.

Publication ,  Journal Article
Rynn, MA; Walkup, JT; Compton, SN; Sakolsky, DJ; Sherrill, JT; Shen, S; Kendall, PC; McCracken, J; Albano, AM; Piacentini, J; Riddle, MA ...
Published in: J Am Acad Child Adolesc Psychiatry
March 2015

OBJECTIVE: To evaluate the frequency of adverse events (AEs) across 4 treatment conditions in the Child/Adolescent Anxiety Multimodal Study (CAMS), and to compare the frequency of AEs between children and adolescents. METHOD: Participants ages 7 to 17 years (mean = 10.7 years) meeting the DSM-IV criteria for 1 or more of the following disorders: separation anxiety disorder, generalized anxiety disorder, or social phobia were randomized (2:2:2:1) to cognitive-behavioral therapy (CBT, n = 139), sertraline (SRT, n = 133), a combination of both (COMB, n = 140), or pill placebo (PBO, n = 76). Data on AEs were collected via a standardized inquiry method plus a self-report Physical Symptom Checklist (PSC). RESULTS: There were no differences between the double-blinded conditions (SRT versus PBO) for total physical and psychiatric AEs or any individual physical or psychiatric AEs. The rates of total physical AEs were greater in the SRT-alone treatment condition when compared to CBT (p < .01) and COMB (p < .01). Moreover, those who received SRT alone reported higher rates of several physical AEs when compared to COMB and CBT. The rate of total psychiatric AEs was higher in children (≤12 years) across all arms (31.7% versus 23.1%, p < .05). Total PSC scores decreased over time, with no significant differences between treatment groups. CONCLUSION: The results support the tolerability/safety of selective serotonin reuptake inhibitor (SSRI) treatment for anxiety disorders even after adjusting for the number of reporting opportunities, leading to no differences in overall rates of AEs. Few differences occurred on specific items. Additional monitoring of psychiatric AEs is recommended in children (≤12 years). Clinical trial registration information-Child and Adolescent Anxiety Disorders (CAMS); http://clinicaltrials.gov; NCT00052078.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Acad Child Adolesc Psychiatry

DOI

EISSN

1527-5418

Publication Date

March 2015

Volume

54

Issue

3

Start / End Page

180 / 190

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Sertraline
  • Selective Serotonin Reuptake Inhibitors
  • Psychiatric Status Rating Scales
  • Phobic Disorders
  • Male
  • Logistic Models
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rynn, M. A., Walkup, J. T., Compton, S. N., Sakolsky, D. J., Sherrill, J. T., Shen, S., … Birmaher, B. (2015). Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry, 54(3), 180–190. https://doi.org/10.1016/j.jaac.2014.12.015
Rynn, Moira A., John T. Walkup, Scott N. Compton, Dara J. Sakolsky, Joel T. Sherrill, Sa Shen, Philip C. Kendall, et al. “Child/Adolescent anxiety multimodal study: evaluating safety.J Am Acad Child Adolesc Psychiatry 54, no. 3 (March 2015): 180–90. https://doi.org/10.1016/j.jaac.2014.12.015.
Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, et al. Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):180–90.
Rynn, Moira A., et al. “Child/Adolescent anxiety multimodal study: evaluating safety.J Am Acad Child Adolesc Psychiatry, vol. 54, no. 3, Mar. 2015, pp. 180–90. Pubmed, doi:10.1016/j.jaac.2014.12.015.
Rynn MA, Walkup JT, Compton SN, Sakolsky DJ, Sherrill JT, Shen S, Kendall PC, McCracken J, Albano AM, Piacentini J, Riddle MA, Keeton C, Waslick B, Chrisman A, Iyengar S, March JS, Birmaher B. Child/Adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):180–190.
Journal cover image

Published In

J Am Acad Child Adolesc Psychiatry

DOI

EISSN

1527-5418

Publication Date

March 2015

Volume

54

Issue

3

Start / End Page

180 / 190

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Sertraline
  • Selective Serotonin Reuptake Inhibitors
  • Psychiatric Status Rating Scales
  • Phobic Disorders
  • Male
  • Logistic Models
  • Humans
  • Female